Fierce Pharma
OCTOBER 10, 2024
As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio. | As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio.
Pharma IQ
OCTOBER 10, 2024
Discover how Enterprise Architecture is transforming healthcare operations, enhancing patient care, and addressing technical debt in the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 10, 2024
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting zbecker Thu, 10/10/2024 - 11:03
MedCity News
OCTOBER 10, 2024
During the Reuters Total Health conference, two healthcare leaders debated whether AI has the potential to reduce healthcare disparities. One argued that the technology is not there yet, while the other argued that it’s about how people use AI. The post Can AI Reduce Healthcare Disparities? Health Execs Debate appeared first on MedCity News.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Fierce Pharma
OCTOBER 10, 2024
As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S. Federal Trade Commission, Lina Khan, Sen. Elizabeth Warren is calling on the antitrust agency to “carefully scrutinize” Novo Holding’s multibillion-dollar bid for CDMO Catalent.
MedCity News
OCTOBER 10, 2024
The idea is to harness the power of digital tools and cloud-based systems to create solutions that understand the root cause of healthcare needs, which will ultimately revolutionize care delivery, improve outcomes and reduce costs. The post Healthcare’s Silver Lining: The Promise of Building a Health System in the Cloud appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
OCTOBER 10, 2024
A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen
Fierce Pharma
OCTOBER 10, 2024
Switzerland’s Competition Commission (COMCO) has dropped its investigation into Novartis’ use of patent actions to quell competition for Cosentyx.
pharmaphorum
OCTOBER 10, 2024
Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.
MedCity News
OCTOBER 10, 2024
Booster Therapeutics’ small molecules activate the 20S proteasome, a component of cells that gets rid of misfolded proteins. Parkinson’s and Alzheimer’s are potential disease targets for the startup, which launched with $15 million in seed financing. The post Startup Booster Therapeutics Launches to Usher In Next Wave of Protein-Degrading Drugs appeared first on MedCity News.
pharmaphorum
OCTOBER 10, 2024
Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management
MedCity News
OCTOBER 10, 2024
Telehealth should serve as a tool for leveling the playing field, ensuring that every person has access to the care they deserve, no matter their socioeconomic status or zip code. The post The Power of “Techquity”: How Telehealth Can Help Promote Health Equity appeared first on MedCity News.
pharmaphorum
OCTOBER 10, 2024
Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.
PharmaTech
OCTOBER 10, 2024
Rafael Ferrer, interim chief business officer at Acino, talked about his company's recent efforts to reach customers in Africa, the Middle East, and most recently, Latin America.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
pharmaphorum
OCTOBER 10, 2024
EVERSANA partners Oracle on pharmacovigilance platform Phil.
Pharmaceutical Technology
OCTOBER 10, 2024
Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, US.
Quantified
OCTOBER 10, 2024
What is an SKO? Key Goals of an SKO Alignment on Objectives Education on New Products Motivation and Recognition Training on New Strategies Step-by-Step Guide to a Successful SKO Step 1: Define Your SKO Purpose Step 2: Plan Interactive and Engaging Activities Step 3: Skip Remote Presentations for Maximum Engagement Step 4: Leverage AI-Powered Simulations for Training Step 5: Involve Executives Throughout the Event Step 6: Follow Up with Ongoing Training and SPIFFs Final Thoughts What is an SKO?
Pharmaceutical Commerce
OCTOBER 10, 2024
Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.
PharmaTech
OCTOBER 10, 2024
Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies.
PharmaTimes
OCTOBER 10, 2024
Sheffield cardiologists demonstrate cutting-edge TAVI procedure
PharmaTech
OCTOBER 10, 2024
Pharmaceutical Technology sat down with Niloufar Salehi, advisor at Eli Lilly & Company, to talk about the session she is moderating at AAPS PharmSci 360 2024, Symposium: An Accelerated Development of Poorly Soluble Drugs Using Predictive Tool.
PharmaTimes
OCTOBER 10, 2024
Teclistamab offers hope for patients exhausting treatment options
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Rep-Lite
OCTOBER 10, 2024
In-house medical recruiters play a critical role in healthcare organizations, ensuring that hospitals and clinics are staffed with qualified professionals. However, behind the scenes, these recruiters face a multitude of challenges that can often lead to frustration, burnout, and inefficiency. In this article, Rep-Lite aims to help you understand these pain points to better assist you in recognizing the evolving nature of medical recruitment and addressing the complexities that impact both recru
PharmaTech
OCTOBER 10, 2024
Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out!
PharmExec
OCTOBER 10, 2024
Data from the Phase III AReSVi-006 clinical trial found that Arexvy offered a cumulative efficacy of 62.9% against lower respiratory tract disease caused by respiratory syncytial virus.
PharmaTech
OCTOBER 10, 2024
Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out!
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Salesforce
OCTOBER 10, 2024
The healthcare and life sciences (HLS) industry is experiencing a rapid digital transformation. From advancements in personalized medicine to the integration of AI and IoT, the potential for innovation is immense. HLS organizations are feeling the pressure to adopt new technologies that improve patient care , boost operational efficiency, and make better use of data.
Evolve Your Success
OCTOBER 10, 2024
Stéphan Toupin, a standout in the medical sales industry, unveils his journey from academia to entrepreneurship, offering listeners an insider perspective on navigating career shifts with purpose and passion. Join us as Stéphan, who traded in his lab coat for a sales portfolio, shares his early realization that pursuing a PhD wasn’t his calling.
European Pharmaceutical Review
OCTOBER 10, 2024
What are the biggest environmental monitoring trends shaping the industry? The introduction of rapid microbiological testing methods, such as biofluorescent particle counters for real time detection of microbial contamination, has had an important impact on cell and gene therapy manufacturing. There is a limited time frame between manufacture and administration that does not allow for traditional sterility testing seen in other types of pharmaceutical manufacturing.
PharmaTech
OCTOBER 10, 2024
Enzene Biosciences CEO Himanshu Gadgil talked about fully connected continuous manufacturing's role in providing equity for biotech companies that may not normally be able to afford such services.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
275 
Let's personalize your content